Wayne Liang(@wliang):If ARKG continues to run as expected into JPM season... I think it's completely reasonable for $NAUT, $PDSB, and $QSI to rally toward ~$10 in the near future. Invalidated if structures break, but generally speaking, betting on biotech in Q4 usually plays out well.

Wayne Liang

@wliang

Asymmetric research. Not financial advice. Get my real-time trade alerts and toolkits: May trade/hold companies discussed.

加入 April 2022

450 正在關注 176.1K 粉絲

Wayne Liang@wliang

2026.10.28 17:04

If ARKG continues to run as expected into JPM season... I think it's completely reasonable for $NAUT, $PDSB, and $QSI to rally toward ~$10 in the near future. Invalidated if structures break, but generally speaking, betting on biotech in Q4 usually plays out well.

Wayne Liang@wliang

2026.10.28 13:46

Multiple buy-signals are starting to appear for $PDSB. If you missed our $NAUT trade for nearly ~3x... probably don't miss out on this? $ARKG (biotech ETF) starting to break out as well, high likelihood we see some aggressive rallies in these smaller caps.